Herrinton Lisa J, Liu Liyan, Alexeeff Stacey, Carolan James, Shorstein Neal H
Division of Research, Kaiser Permanente Northern California, Oakland, California.
Department of Ophthalmology, Kaiser Permanente San Rafael, San Rafael, California.
Ophthalmology. 2017 Aug;124(8):1126-1135. doi: 10.1016/j.ophtha.2017.03.034. Epub 2017 Apr 21.
We conducted a retrospective comparative-effectiveness study of best-corrected visual acuity (BCVA) and refractive error (RE) after immediate sequential (ISBCS) and delayed sequential (DSBCS) bilateral cataract surgery. We tested 2 hypotheses: (1) among DSBCS patients, second-eye outcomes were no different than first-eye outcomes; (2) averaged between each patient's 2 eyes, outcomes did not differ between ISBCS and DSBCS patients.
Retrospective comparative-effectiveness study.
Kaiser Permanente Northern California members who underwent noncomplex bilateral cataract surgery from January 1, 2013, through June 30, 2015.
We performed an intention-to-treat analysis comparing ISBCS to DSBCS using conditional logistic regression analysis, accounting for surgeon and patient-level factors.
BCVA, RE.
The analysis of visual outcomes included both eyes of 13 711 DSBCS and 3561 ISBCS patients. Because of the large sample size, some statistical differences lacked clinical significance. Ocular comorbidities were slightly more prevalent in DSBCS patients. Postoperative BCVA was 20/20 or better in 48% of DSBCS first eyes, 49% of DSBCS second eyes, 53% of ISBCS right eyes, and 51% of ISBCS left eyes. The within-person difference in postoperative BCVA averaged zero (0.00) between the first and second DSBCS eyes, and between the ISBCS right and left eyes. After adjustment, average postoperative BCVA was better in ISBCS patients, although the difference was not statistically significant (compared with 20/20 or better: odds ratio for worse than 20/20 was 0.91, 95% confidence interval 0.83-1.01). Emmetropia (spherical equivalent -0.5 to 0 diopter) was achieved in 61% of first DSBCS eyes, 61% of second DSBCS eyes, 63% of ISBCS right eyes, and 63% of ISBCS left eyes. After adjustment, average postoperative RE was no different in ISBCS compared with DSBCS patients (compared with emmetropia: odds ratio for ametropia was 1.02, confidence interval 0.92-1.12). We confirmed 1 case of postoperative endophthalmitis in 10 494 ISBCS eyes (1.0 per 10 000 eyes) and 2 cases in 38 736 DSBCS eyes (0.5 per 10 000 eyes) (P = 0.6), and no patient had bilateral endophthalmitis.
Compared with DSBCS, we found no evidence that ISBCS was associated with worse postoperative BCVA or RE, or with an increased complication risk.
我们开展了一项回顾性比较有效性研究,对比即刻连续(ISBCS)和延迟连续(DSBCS)双侧白内障手术后的最佳矫正视力(BCVA)和屈光不正(RE)情况。我们检验了两个假设:(1)在DSBCS患者中,第二眼的手术效果与第一眼无差异;(2)每位患者的两只眼睛平均来看,ISBCS和DSBCS患者的手术效果无差异。
回顾性比较有效性研究。
2013年1月1日至2015年6月30日期间在北加利福尼亚凯撒医疗集团接受非复杂性双侧白内障手术的成员。
我们采用条件逻辑回归分析,进行意向性分析,比较ISBCS和DSBCS,并考虑外科医生和患者层面的因素。
BCVA、RE。
视觉效果分析纳入了13711例DSBCS患者和3561例ISBCS患者的双眼。由于样本量较大,一些统计学差异缺乏临床意义。眼部合并症在DSBCS患者中略为常见。DSBCS第一眼术后BCVA为20/20或更好的比例为48%,DSBCS第二眼为49%,ISBCS右眼为53%,ISBCS左眼为51%。DSBCS的第一眼和第二眼之间以及ISBCS的右眼和左眼之间,术后BCVA的个体内差异平均为零(0.00)。调整后,ISBCS患者术后平均BCVA更好,尽管差异无统计学意义(与20/20或更好相比:低于20/20的比值比为0.91,95%置信区间为0.83 - 1.01)。DSBCS第一眼的61%、DSBCS第二眼的61%、ISBCS右眼的63%和ISBCS左眼的63%达到正视(球镜等效度数为-0.5至0屈光度)。调整后,ISBCS患者术后平均RE与DSBCS患者无差异(与正视相比:屈光不正的比值比为1.02,置信区间为0.92 - 1.12)。我们在10494例ISBCS眼中确诊1例术后眼内炎(每10000只眼1.0例),在38736例DSBCS眼中确诊2例(每10000只眼0.5例)(P = 0.6),且无患者发生双侧眼内炎。
与DSBCS相比,我们没有发现证据表明ISBCS与术后更差的BCVA或RE相关,也没有发现其与并发症风险增加相关。